secwatch.observer — SEC 8-K summary
======================================

Issuer:     TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK:        0001630627
Form:       8-K
Filed at:   2022-02-25T23:59:59+00:00
Accession:  0000950170-22-002108
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

John R. Treace to retire from board; Chairman James T. Treace reclassified as Class I director
--------------------------------------------------------------------------------

- John R. Treace (father of CEO) will retire at the 2022 annual meeting and not stand for re-election.
- Decision not related to any disagreement with the Company's operations, policies, or disclosures.
- Board approved reclassification of Chairman James T. Treace to Class I director, effective upon John R. Treace's term expiration.
- James T. Treace will stand for election as a Class I Director at the 2022 Annual Meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630627/000095017022002108/0000950170-22-002108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630627/000095017022002108/tmci-20220222.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-002108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer